HKD 11.24
(1.81%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -507.74 Million CNY | -61.8% |
2022 | -346.75 Million CNY | 3.54% |
2021 | -359.48 Million CNY | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -86.05 Million CNY | 0.0% |
2024 Q1 | -86.05 Million CNY | 40.49% |
2023 Q4 | -144.6 Million CNY | -24.75% |
2023 Q3 | -115.91 Million CNY | 10.16% |
2023 FY | -561.06 Million CNY | -61.8% |
2023 Q2 | -129.03 Million CNY | 0.0% |
2023 Q1 | -129.03 Million CNY | -15.61% |
2022 FY | -346.75 Million CNY | 3.54% |
2022 Q4 | -111.6 Million CNY | 0.0% |
2021 FY | -359.48 Million CNY | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Uni-Bio Science Group Limited | 70.87 Million HKD | 816.389% |
CK Life Sciences Int'l., (Holdings) Inc. | 17.25 Million HKD | 3043.467% |